EIS Eczacibasi Ilaç, Sinai ve Finansal Yatirimlar Sanayi ve Ticaret A.S.
BIST:ECILC.IS
48.78 (TRY) • At close September 6, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) TRY.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 6,479.496 | 1,830.613 | 1,103.515 | 909.132 | 877.076 | 692.094 | 597.909 | 1,412.645 | 1,170.563 | 1,046.781 | 1,126.009 | 1,087.267 | 973.552 | 913.212 | 874.7 | 805.315 | 921.8 | 996.315 | 847.858 | 847.768 |
| Cost of Revenue
| 4,291.709 | 1,166.604 | 762.136 | 608.463 | 561.262 | 447.692 | 363.476 | 1,056.19 | 907.688 | 856.52 | 919.875 | 828.198 | 712.133 | 646.718 | 628.723 | 586.662 | 626.298 | 639.528 | 571.043 | 556.11 |
| Gross Profit
| 2,187.787 | 664.009 | 341.379 | 300.669 | 315.814 | 244.402 | 234.433 | 356.455 | 262.875 | 190.261 | 206.134 | 259.069 | 261.419 | 266.494 | 245.977 | 218.652 | 295.502 | 356.788 | 276.815 | 291.658 |
| Gross Profit Ratio
| 0.338 | 0.363 | 0.309 | 0.331 | 0.36 | 0.353 | 0.392 | 0.252 | 0.225 | 0.182 | 0.183 | 0.238 | 0.269 | 0.292 | 0.281 | 0.272 | 0.321 | 0.358 | 0.326 | 0.344 |
| Reseach & Development Expenses
| 106.323 | 5.946 | 2.075 | 1.773 | 3.362 | 1.168 | 1.308 | 1.85 | 1.361 | 1.098 | 1.053 | 0.704 | 0.139 | 0.016 | 0.191 | 0.459 | 4.065 | 7.261 | 7.408 | 5.779 |
| General & Administrative Expenses
| 341.473 | 74.032 | 33.555 | 28.297 | 20.956 | 16.094 | 18.28 | 28.355 | 26.273 | 25.267 | 23.16 | 50.032 | 101.101 | 91.016 | 86.823 | 83.168 | 109.433 | 100.451 | 89.323 | 0 |
| Selling & Marketing Expenses
| 523.231 | 181.848 | 84.844 | 54.116 | 61.451 | 61.552 | 59.245 | 116.426 | 87.495 | 71.828 | 62.097 | 84.221 | 136.493 | 132.56 | 132.021 | 130.96 | 170.473 | 182.39 | 153.66 | 0 |
| SG&A
| 864.704 | 255.88 | 118.399 | 82.413 | 82.407 | 77.646 | 77.525 | 144.781 | 113.768 | 97.095 | 85.257 | 134.253 | 237.594 | 223.576 | 218.844 | 214.128 | 279.905 | 282.841 | 242.983 | 0 |
| Other Expenses
| 1,137.659 | 11.416 | 3.239 | 4.623 | 16.668 | -22.228 | -6.518 | -9.681 | -13.702 | 0 | 0 | 0.6 | 0 | 0 | 0 | 0 | 471.448 | 25.738 | 17.731 | 0 |
| Operating Expenses
| 1,947.147 | 476.3 | 254.801 | 185.291 | 190.488 | 192.034 | 178.836 | 310.238 | 258.349 | 205.736 | 196.618 | 263.951 | 250.717 | 215.784 | 230.534 | 222.228 | 283.971 | 290.103 | 250.391 | 142.623 |
| Operating Income
| 894.759 | 687.08 | 691.053 | 297.205 | 224.906 | 208.363 | 129.059 | 154.908 | 123.779 | 18.508 | 134.683 | 22.266 | 10.702 | 50.71 | 15.443 | -3.576 | 11.531 | 66.685 | 26.424 | 62.987 |
| Operating Income Ratio
| 0.138 | 0.375 | 0.626 | 0.327 | 0.256 | 0.301 | 0.216 | 0.11 | 0.106 | 0.018 | 0.12 | 0.02 | 0.011 | 0.056 | 0.018 | -0.004 | 0.013 | 0.067 | 0.031 | 0.074 |
| Total Other Income Expenses Net
| 2,207.366 | 3,891.481 | 248.426 | 88.761 | -31.789 | 86.888 | 41.818 | 42.28 | -50.126 | -69.362 | -47.653 | 22.373 | 110.502 | 27.48 | 303.583 | 92.327 | 470.23 | -4.718 | 17.758 | 0 |
| Income Before Tax
| 3,102.125 | 4,578.561 | 939.479 | 385.966 | 193.117 | 295.251 | 170.877 | 197.188 | 73.653 | -50.854 | 87.03 | 44.639 | 121.204 | 78.19 | 319.026 | 88.751 | 481.761 | 61.967 | 44.182 | 0 |
| Income Before Tax Ratio
| 0.479 | 2.501 | 0.851 | 0.425 | 0.22 | 0.427 | 0.286 | 0.14 | 0.063 | -0.049 | 0.077 | 0.041 | 0.124 | 0.086 | 0.365 | 0.11 | 0.523 | 0.062 | 0.052 | 0 |
| Income Tax Expense
| 362.214 | 400.485 | 184.407 | 63.852 | 30.389 | 55.162 | 28.137 | 29.631 | 18.674 | 10.39 | 28.996 | 9.449 | 30.823 | 15.019 | 26.843 | 18.301 | 27.43 | 18.729 | 4.657 | 16.21 |
| Net Income
| 2,739.838 | 4,177.76 | 755.06 | 322.089 | 162.728 | 240.119 | 146.095 | 184.803 | 67.647 | -43.293 | 61.414 | 32.689 | 88.51 | 60.38 | 290.249 | 72.409 | 454.331 | 43.238 | 39.524 | 46.777 |
| Net Income Ratio
| 0.423 | 2.282 | 0.684 | 0.354 | 0.186 | 0.347 | 0.244 | 0.131 | 0.058 | -0.041 | 0.055 | 0.03 | 0.091 | 0.066 | 0.332 | 0.09 | 0.493 | 0.043 | 0.047 | 0.055 |
| EPS
| 4 | 6.1 | 1.1 | 0.47 | 0.24 | 0.35 | 0.21 | 0.27 | 0.11 | -0.063 | 0.09 | 0.048 | 0.13 | 0.088 | 0.42 | 0.11 | 0.66 | 0.063 | 0.058 | 0.068 |
| EPS Diluted
| 4 | 6.1 | 1.1 | 0.47 | 0.24 | 0.35 | 0.21 | 0.27 | 0.11 | -0.063 | 0.09 | 0.048 | 0.13 | 0.088 | 0.42 | 0.11 | 0.66 | 0.063 | 0.058 | 0.068 |
| EBITDA
| 2,202.322 | 3,767.583 | 935.288 | 411.44 | 260.297 | 310.244 | 127.431 | 244.09 | 131.07 | -8.892 | 118.403 | 95.243 | 31.361 | 70.051 | 35.727 | 380.252 | 39.342 | 101.52 | 56.931 | 149.035 |
| EBITDA Ratio
| 0.34 | 2.058 | 0.848 | 0.453 | 0.297 | 0.448 | 0.213 | 0.173 | 0.112 | -0.008 | 0.105 | 0.088 | 0.032 | 0.077 | 0.041 | 0.472 | 0.043 | 0.102 | 0.067 | 0.176 |